Human CD4- invariant NKT lymphocytes regulate graft versus host disease

Area of Science:

• Immunology
• Cellular Immunology
• Transplantation Immunology

Background:

• Invariant natural killer T (iNKT) cells show promise in controlling graft-versus-host disease (GVHD).
• Mechanisms of iNKT cell-mediated regulation of allogeneic immune responses in humans remain unclear.
• Distinct roles of human CD4+ and CD4- iNKT cell subsets in GVHD are not well understood.

Purpose of the Study:

• To investigate the differential effects of human CD4+ and CD4- iNKT cell subsets on T cell activation and GVHD.
• To elucidate the mechanisms by which iNKT cell subsets modulate dendritic cell maturation and survival.
• To evaluate the potential of CD4- iNKT cells for GVHD prevention in a humanized mouse model.

Main Methods:

• Human CD4+ and CD4- iNKT cells were expanded and flow-sorted.
• Pre-clinical xenogeneic GVHD model using humanized NSG mice.
• Co-culture experiments with dendritic cells (DCs) and iNKT cells in vitro.
• Analysis of T cell activation, differentiation, and DC maturation/apoptosis in vivo and in vitro.

Main Results:

• Human CD4- iNKT cells, but not CD4+ iNKT cells, significantly controlled xenogeneic GVHD, prolonging survival and reducing GVHD scores.
• CD4- iNKT cells suppressed T cell activation and Th1/Th17 differentiation in vivo.
• CD4- iNKT cells induced apoptosis in mouse and human dendritic cells more effectively than CD4+ iNKT cells in vitro and in vivo.

Conclusions:

• Human CD4- iNKT cells possess potent immunosuppressive functions against alloreactivity compared to CD4+ iNKT cells.
• CD4- iNKT cells control GVHD by modulating T cell responses and inducing dendritic cell apoptosis.
• Selective expansion or transfer of CD4- iNKT cells offers a promising strategy for preventing GVHD in clinical settings.